Studies have shown that FTSJ1 inhibits the malignancy of non-small cell lung cancer (NSCLC) by regulating tRNA 2′-O-methyladenosine modification and inhibiting the expression of DNA-damage-regulated autophagy regulator 1 (DRAM1) [16]. This evidence concerns the gene FTSJ1 and non-small cell lung carcinoma.